| [1] |
Pabinger I,van Es N,Heinze G, et al. A clinical prediction model for cancer－associated venous thromboembolism: a development and validation study in two independent prospective cohorts[J]. Lancet Haematol, 2018, 5(7): e289－e298.
|
| [2] |
Higginson J．International Agency for Research on Cancer[J]. Arch Pathol, 1974, 98(5): 289－291.
|
| [3] |
Lee KW,Bang SM,Kim S, et al. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer[J]. J Thromb Haemost, 2010, 8(3): 540－547.
|
| [4] |
Lyman GH,Khorana AA,Falanga A, et al.American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer[J]. J Clin Oncol, 2007, 25(34): 5490－5505.
|
| [5] |
Aleman MM,Byrnes JR,Wang JG, et al. Factor XIII activity mediates red blood cell retention in venous thrombi[J]. J Clin Invest, 2014, 124(8): 3590－3600.
|
| [6] |
Van Der Meijden, PE,Van Schifgaarde M,Van Oerle R, et al. Platelet and erythrocytederived microparticles trigger thrombin generation via factor XIIa[J]. J Thromb Haemost, 2012, 10(7): 1355－1362.
|
| [7] |
Cai FQ,Jing YH,Gao YF, et al. [Immune adherence(C3b) receptor activity of erythrocytes in patients with esophageal cancer and cancer of the gastric cardia][J]. Zhonghua Zhong Liu Za Zhi, 1986, 8(4): 253－255.
|
| [8] |
何晓凤，李秋．血小板相关抗体及膜糖蛋白在胃癌患者中的临床检测意义探析[J]．中国实验诊断学，2018，22(7): 1174－1176.
|
| [9] |
Du T,Tan Z. Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors[J]. Braz J Med Biol Res, 2014, 47(11): 1003－1007.
|
| [10] |
Khorana AA,Kuderer NM,Culakova E, et al. Development and validation of a predictive model for chemotherapy－associated thrombosis[J]. Blood, 2008, 111(10): 4902－4907.
|
| [11] |
Fuentes HE,Paz LH,Wang Y, et al. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment[J]. Clin Appl Thromb Hemost, 2018, 24(5): 790－796.
|
| [12] |
Wolberg AS,Rosndaal FR,Weitz JI, et al.Venous thrombosis[J]. Nat Rev Dis Primers, 2015, 1: 15006－15006.
|
| [13] |
Semeraro F,Ammollo CT,Morrissey JH, et al.Extracellular histones promote thrombin generation through platelet－dependent mechanisms: involvement of platelet TLR2 and TLR4[J]. Blood, 2011, 118(7): 1952－1961.
|
| [14] |
Du T,Tan Z. Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors[J]. Braz J Med Biol Res, 2014, 47(11): 1003－1007.
|
| [15] |
Mo J,Bai B,Li Y,Deng J, et al. Expression of interleukin－18 in a rat model of deep vein thrombosis[J]. J Cardiovasc Surg (Torino), 2012, 53(5): 625－630.
|
| [16] |
Lo L,Valentine H,Harrison J, et al.Tissue factor expression in the metaplasia－adenoma－carcinoma sequence of gastric cancer in a European population[J]. Br J Cancer, 2012, 107(7): 1125－1130.
|
| [17] |
马玉滨，燕速，于鹏杰，等．低氧诱导因子－1α在胃癌组织中表达水平及分子作用机制研究[J]．中国免疫学杂志，2017，33(12): 1799－1803.
|
| [18] |
Rao B,Gao Y,Huang J, et al. Mutations of p53 and K－ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis[J]. Int J Colorectal Dis, 2011, 26(5): 593－601.
|
| [19] |
张雪，姜达，李颖．肿瘤相关性高凝的分子机制[J]．国际肿瘤学杂志，2016，43(5): 356－359.
|
| [20] |
Kee NL,Krause J,Blatch GL, et al. The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation[J]. Protein J, 2015, 34(5): 338－348.
|
| [21] |
郭菲，黄立娟．微粒在血栓形成中的研究进展[J]．国际免疫学杂志，2012，35(5): 346－349.
|
| [22] |
姜璐，汪希鹏．血小板微粒相关研究进展[J]．国际妇产科学杂志，2015，42(3): 306－310.
|
| [23] |
Osaki T,Saito H,Fukumoto Y, et al. Risk and incidence of perioperative deep vein thrombosis in patients undergoing gastric cancer surgery[J]. Surg Today, 2018, 48(5): 525－533.
|
| [24] |
严冬华，俞文渊，陈涛，等．腹腔镜及开腹远端胃癌根治术对机体凝血及免疫功能的影响分析[J]．中国血液流变学杂志，2016，26(3): 346－348，369.
|
| [25] |
王瑜，王燕婷，蒋彦彦，等．不同体位和不同压力的CO2气腹对腹腔镜手术患者下肢深静脉血流动力学的影响[J]．中华胃肠外科杂志，2009，12(4): 361－363.
|
| [26] |
赵高平，贾贵清，黎熊，等．腹腔镜辅助与常规开腹手术治疗胃癌近期疗效分析[J]．中国临床研究，2016，29(7): 888－891.
|
| [27] |
史枫，刘海龙，李桢，等．腹腔镜与开腹手术后下肢DVT发生率比较的Meta分析[J]．山东医药，2015，55(10): 48－50.
|
| [28] |
Abdelrazeq AS,Dwaik MA,Aldoori MI, et al.Laparoscopy－associated portal vein thrombosis: description of an evolving clinical syndrome[J]. J Laparoendosc Adv Surg Tech A, 2006, 16(1): 9－14.
|
| [29] |
龚建军，梁亚萍，牛建华，等．不同气腹压力对腹腔镜胆囊切除术凝血－纤溶指标的影响[J]．临床和实验医学杂志，2013，12(6): 420－422.
|
| [30] |
段启瑞，邱颐，王彩霞．麻醉方式与药物对静脉血栓的影响及防治研究进展[J]．内蒙古医科大学学报，2017，39(4): 381－385.
|
| [31] |
储靖，陈宁，杨程．血栓弹力图检测5种不同液体用于术前预扩容对凝血功能的影响[J]．河北医药，2013，35(9): 1348－1349.
|
| [32] |
叶华，陈平，郑祺，等．胃癌术后早期应用低分子肝素对静脉血栓形成的影响[J]．中华普通外科杂志，2014，29(11): 875－876.
|
| [33] |
吕华新．分析肝胆外科手术患者并发下肢深静脉血栓形成的危险因素[J]．中国实用医药，2013，8(8): 130－131.
|
| [34] |
郜永顺，黄晶晶，陈鹏，等．胃肠外科围手术期下肢深静脉血栓形成的临床分析[J]．中华普通外科杂志，2016，31(11): 940－943.
|
| [35] |
龙文彬．恶性肿瘤诊疗中血液流变学检验的应用[J]．医学信息，2013，26(9): 682－682.
|
| [36] |
Nam SY,Ko YS,Jung J, et al. A hypoxia－dependent upregulation of hypoxia－inducible factor－1 by nuclear factor－κB promotes gastric tumour growth and angiogenesis[J]. Br J Cancer, 2011, 104(1): 166－174.
|
| [37] |
Wojtukiewicz MZ,Sierko E,Zacharski LR, et al. Tissue factor－dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer[J]. Semin Thromb Hemost, 2003, 29(3): 291－300.
|
| [38] |
张静峥，顾健．炎症体与肿瘤相关血栓形成的研究进展[J]．中国实验血液学杂志，2016，24(4): 1260－1263.
|
| [39] |
谭红平．胃癌患者围术期血液流变性变化的临床研究[J]．现代临床医学，2011，37(4): 261－263.
|
| [40] |
张少伟，刘建洛，白明辉．腹腔镜胃癌手术与开腹手术对患者凝血功能的影响[J]．中国老年学杂志，2012，32(18): 4036－4037.
|